Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

29.11USD
4:00pm EDT
Price Change (% chg)

$-0.12 (-0.41%)
Prev Close
$29.23
Open
$29.45
Day's High
$29.45
Day's Low
$28.98
Volume
7,993,382
Avg. Vol
11,993,037
52-wk High
$31.14
52-wk Low
$23.55

PFE.N

Chart for PFE.N

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition. The Company’s diversified global healthcare portfolio... (more)

Overall

Beta: 0.73
Market Cap (Mil.): $207,334.91
Shares Outstanding (Mil.): 7,093.22
Dividend: 0.24
Yield (%): 3.28

Financials

  PFE.N Industry Sector
P/E (TTM): 19.88 37.93 37.76
EPS (TTM): 1.47 -- --
ROI: -- 19.48 18.76
ROE: -- 20.17 19.59
Search Stocks

US STOCKS-S&P 500, Nasdaq end up as tech gains; potash shares sink

* Mosaic, Potash Corp sink after Russia quits top potash cartel

30 Jul 2013

Pfizer settles U.S. marketing case related to Rapamune

WASHINGTON - Pfizer Inc will pay $490.9 million to resolve accusations of illegal marketing of the drug Rapamune dating to Pfizer's 2009 acquisition of Wyeth Pharmaceuticals Inc, the U.S. Justice Department said on Tuesday.

30 Jul 2013

UPDATE 1-Pfizer settles U.S. marketing case related to Rapamune

WASHINGTON, July 30 - Pfizer Inc will pay $490.9 million to resolve accusations of illegal marketing of the drug Rapamune dating to Pfizer's 2009 acquisition of Wyeth Pharmaceuticals Inc, the U.S. Justice Department said on Tuesday.

30 Jul 2013

Cost controls help Pfizer, Merck weather weak quarter

- Big Pharma is still relying on belt-tightening to prop up financial results.

30 Jul 2013

WRAPUP 1-Cost controls help Pfizer, Merck weather weak quarter

July 30 - Big Pharma is still relying on belt-tightening to prop up financial results.

30 Jul 2013

US STOCKS-Wall St rises on earnings; potash selloff reins in S&P

* Mosaic, Potash Corp sink after Russia quits top potash cartel

30 Jul 2013

US STOCKS-Wall Street rises on earnings; potash cos down

* Mosaic, Potash Corp tumble after Russia quits top potash cartel

30 Jul 2013

US STOCKS-Futures tick higher ahead of data, Fed in focus

* Mosaic, Potash Corp tumble after Russia quits top potash cartel

30 Jul 2013

Pfizer earnings top estimates, reiterates forecast

- Pfizer Inc reported second-quarter earnings slightly ahead of estimates on Tuesday as the largest U.S. drugmaker lines up a business split that could lead to the spinoff of its generics division.

30 Jul 2013

REFILE-US STOCKS-Futures tick higher before data, Fed in focus

* Mosaic, Potash Corp tumble after Russia quits top potash cartel

30 Jul 2013

Competitors

  Price Change
The Procter & Gamble Company (PG.N) $81.64 +1.34
Johnson & Johnson (JNJ.N) $93.77 +0.27
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.58 +0.41
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Abbott Laboratories (ABT.N) $36.84 +0.21
Bayer AG (BAYGn.DE) €89.43 +2.08
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.85 -3.32
AstraZeneca plc (AZN.L) 3,334.00p -1.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$58.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$495.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks